Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens.
Peripheral T-cell lymphomas (PTCL) are generally less common and pursue a more aggressive clinical course than B-cell lymphomas, with the T-cell phenotype itself being a poor prognostic factor in adult non-Hodgkin lymphoma (NHL). With notable exceptions such as ALK(+) anaplastic large cell lymphoma...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Public Library of Science
2011
|
| _version_ | 1826293149828382720 |
|---|---|
| author | Cooper, C Lawrie, C Liggins, A Collins, G Hatton, C Pulford, K Banham, A |
| author_facet | Cooper, C Lawrie, C Liggins, A Collins, G Hatton, C Pulford, K Banham, A |
| author_sort | Cooper, C |
| collection | OXFORD |
| description | Peripheral T-cell lymphomas (PTCL) are generally less common and pursue a more aggressive clinical course than B-cell lymphomas, with the T-cell phenotype itself being a poor prognostic factor in adult non-Hodgkin lymphoma (NHL). With notable exceptions such as ALK(+) anaplastic large cell lymphoma (ALCL, ALK+), the molecular abnormalities in PTCL remain poorly characterised. We had previously identified circulating antibodies to ALK in patients with ALCL, ALK(+). Thus, as a strategy to identify potential antigens associated with the pathogenesis of PTCL, not otherwise specified (PTCL, NOS), we screened a testis cDNA library with sera from four PTCL, NOS patients using the SEREX (serological analysis of recombinant cDNA expression libraries) technique. We identified nine PTCL, NOS-associated antigens whose immunological reactivity was further investigated using sera from 52 B- and T-cell lymphoma patients and 17 normal controls. The centrosomal protein CEP250 was specifically recognised by patients sera and showed increased protein expression in cell lines derived from T-cell versus B-cell malignancies. TCEB3, BECN1, and two previously uncharacterised proteins, c14orf93 and ZBTB44, were preferentially recognised by patients' sera. Transcripts for all nine genes were identified in 39 cancer cell lines and the five genes encoding preferentially lymphoma-recognised antigens were widely expressed in normal tissues and mononuclear cell subsets. In summary, this study identifies novel molecules that are immunologically recognised in vivo by patients with PTCL, NOS. Future studies are needed to determine whether these tumor antigens play a role in the pathogenesis of PTCL. |
| first_indexed | 2024-03-07T03:25:39Z |
| format | Journal article |
| id | oxford-uuid:b8ef9bcc-266a-4690-95e5-9d1a449dab3d |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T03:25:39Z |
| publishDate | 2011 |
| publisher | Public Library of Science |
| record_format | dspace |
| spelling | oxford-uuid:b8ef9bcc-266a-4690-95e5-9d1a449dab3d2022-03-27T04:59:29ZIdentification and characterization of peripheral T-cell lymphoma-associated SEREX antigens.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b8ef9bcc-266a-4690-95e5-9d1a449dab3dEnglishSymplectic Elements at OxfordPublic Library of Science2011Cooper, CLawrie, CLiggins, ACollins, GHatton, CPulford, KBanham, APeripheral T-cell lymphomas (PTCL) are generally less common and pursue a more aggressive clinical course than B-cell lymphomas, with the T-cell phenotype itself being a poor prognostic factor in adult non-Hodgkin lymphoma (NHL). With notable exceptions such as ALK(+) anaplastic large cell lymphoma (ALCL, ALK+), the molecular abnormalities in PTCL remain poorly characterised. We had previously identified circulating antibodies to ALK in patients with ALCL, ALK(+). Thus, as a strategy to identify potential antigens associated with the pathogenesis of PTCL, not otherwise specified (PTCL, NOS), we screened a testis cDNA library with sera from four PTCL, NOS patients using the SEREX (serological analysis of recombinant cDNA expression libraries) technique. We identified nine PTCL, NOS-associated antigens whose immunological reactivity was further investigated using sera from 52 B- and T-cell lymphoma patients and 17 normal controls. The centrosomal protein CEP250 was specifically recognised by patients sera and showed increased protein expression in cell lines derived from T-cell versus B-cell malignancies. TCEB3, BECN1, and two previously uncharacterised proteins, c14orf93 and ZBTB44, were preferentially recognised by patients' sera. Transcripts for all nine genes were identified in 39 cancer cell lines and the five genes encoding preferentially lymphoma-recognised antigens were widely expressed in normal tissues and mononuclear cell subsets. In summary, this study identifies novel molecules that are immunologically recognised in vivo by patients with PTCL, NOS. Future studies are needed to determine whether these tumor antigens play a role in the pathogenesis of PTCL. |
| spellingShingle | Cooper, C Lawrie, C Liggins, A Collins, G Hatton, C Pulford, K Banham, A Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens. |
| title | Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens. |
| title_full | Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens. |
| title_fullStr | Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens. |
| title_full_unstemmed | Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens. |
| title_short | Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens. |
| title_sort | identification and characterization of peripheral t cell lymphoma associated serex antigens |
| work_keys_str_mv | AT cooperc identificationandcharacterizationofperipheraltcelllymphomaassociatedserexantigens AT lawriec identificationandcharacterizationofperipheraltcelllymphomaassociatedserexantigens AT ligginsa identificationandcharacterizationofperipheraltcelllymphomaassociatedserexantigens AT collinsg identificationandcharacterizationofperipheraltcelllymphomaassociatedserexantigens AT hattonc identificationandcharacterizationofperipheraltcelllymphomaassociatedserexantigens AT pulfordk identificationandcharacterizationofperipheraltcelllymphomaassociatedserexantigens AT banhama identificationandcharacterizationofperipheraltcelllymphomaassociatedserexantigens |